Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Fèvre-Montange, Alexandre Vasiljevic, D. Frappaz, J. Champier, A. Szathmari, M.-H. Lorton, Françoise Chapon, A. Coulon, I. Roué, Marie Delisle, Dominique Figarella-Branger, Annie Laquerrière, Catherine Miquel, Jean-François Michiels, M. Péoch, Marc Polivka, F. Fauchon, Anne Jouvet (2012)
Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre studyNeuropathology and Applied Neurobiology, 38
K. Fukuoka, A. Sasaki, T. Yanagisawa, Tomonari Suzuki, K. Wakiya, J. Adachi, K. Mishima, T. Fujimaki, M. Matsutani, R. Nishikawa (2012)
Pineal parenchymal tumor of intermediate differentiation with marked elevation of MIB-1 labeling indexBrain Tumor Pathology, 29
Bomi Kim, Dong Kim, Sung-Hye Park (2009)
Pineal parenchymal tumor of intermediate differentiation showing malignant progression at relapseNeuropathology, 29
Navneet Singla, A. Kapoor, S. Dhandapani, B. Radotra, D. Chatterjee (2016)
Revisiting the metastatic potential of childhood pineal parenchymal tumor of intermediate differentiation: a case reportChild's Nervous System, 32
A. Amato-Watkins, A. Lammie, C. Hayhurst, P. Leach (2016)
Pineal parenchymal tumours of intermediate differentiation – An evidence-based review of a new pathological entityBritish Journal of Neurosurgery, 30
Hiromi Kanno, H. Nishihara, Mitsuteru Oikawa, Y. Ozaki, J. Murata, Y. Sawamura, Masahito Kato, K. Kubota, M. Tanino, Taichi Kimura, K. Nagashima, Tamio Itoh, S. Tanaka (2012)
Expression of O6‐methylguanine DNA methyltransferase (MGMT) and immunohistochemical analysis of 12 pineal parenchymal tumorsNeuropathology, 32
D. Raleigh, D. Solomon, S. Lloyd, A. Lazar, Michael Garcia, P. Sneed, Jennifer Clarke, M. McDermott, M. Berger, T. Tihan, D. Haas-Kogan (2017)
Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcomeNeuro-Oncology, 19
S. Mallick, R. Benson, G. Rath (2016)
Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: An individual patient data analysis.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 121 2
J. Yi, Hyo-jeong Kim, Young-jin Choi, Y. Seol, D. Kahng, Y. Choi, Eun-kyoung Park (2013)
Successful Treatment by Chemotherapy of Pineal Parenchymal Tumor with Intermediate Differentiation: A Case ReportCancer Research and Treatment : Official Journal of Korean Cancer Association, 45
A. Arivazhagan, B. Anandh, V. Santosh, B. Chandramouli (2008)
Pineal parenchymal tumors--utility of immunohistochemical markers in prognostication.Clinical neuropathology, 27 5
Tsubasa Watanabe, T. Mizowaki, Y. Arakawa, Y. Iizuka, K. Ogura, K. Sakanaka, S. Miyamoto, M. Hiraoka (2014)
Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases.Molecular and clinical oncology, 2 2
P. Das, S. Mckinstry, A. Devadass, B. Herron, D. Conkey (2016)
Are we over treating Pineal Parenchymal tumour with intermediate differentiation? Assessing the role of localised radiation therapy and literature reviewSpringerPlus, 5
Tamio Ito, Hiromi Kanno, Kenichi Sato, Mitsuteru Oikawa, Y. Ozaki, Hirohiko Nakamura, S. Terasaka, Hiroyuki Kobayashi, K. Houkin, K. Hatanaka, Jyun-ichi Murata, S. Tanaka (2014)
Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation.World neurosurgery, 81 5-6
Tao Yu, Xingwen Sun, Junmei Wang, X. Ren, N. Lin, Song Lin (2015)
Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosisJournal of Neurology, Neurosurgery & Psychiatry, 87
A. Jouvet, G. Saint-Pierre, F. Fauchon, K. Privat, E. Bouffet, M. Ruchoux, L. Chauveinc, M. Fèvre-Montange (2000)
Pineal Parenchymal Tumors: A Correlation of Histological Features with Prognosis in 66 CasesBrain Pathology, 10
Introduction:Pineal parenchymal tumor of intermediate differentiation (PPTID) is an uncommon tumor of the pineal gland. Although this behaves as a grade II/III tumor, the exact clinical behavior is not well known. There is no well-established pathologic factor that can predict the behavior of PPTID.Aim and Objective:The aim of this study was to determine the pathologic prognostic factors in PPTID.Materials and Methods:All PPTID cases diagnosed between 2006 and 2016 were analyzed retrospectively. Immunohistochemistry for synaptophysin, neurofilament protein (NFP), glial fibrillar acid protein, NeuN, and Ki-67 were performed in all cases. Cases were classified arbitrarily into low grade (mitosis <4/10 hpf and Ki-67 <5%) and high grade (mitosis ≥4/10 hpf and Ki-67 ≥5%). Clinical details including follow-up information were retrieved from the patients’ files.Results:A total of 16 patients (6 low grade and 10 high grade) were included in this study. The age ranged from 2 to 55 years (average, 28.2) with a mild male preponderance (male:female, 1.67:1). All cases showed strong and diffuse positivity for synaptophysin. Focal NFP positivity was seen in 2 low-grade and 3 high-grade tumors. Only 2 cases showed focal NeuN positivity. Average Ki-67 index was 1.7% and 12.6% in low-grade and high-grade tumors, respectively. All patients with low-grade tumor were alive without recurrence. Among the patients with high-grade tumors, 2 had local recurrence, 1 had spinal metastasis, and 3 patients died.Conclusion:Mitosis and Ki-67 proliferation index are the most important pathologic prognostic factors in PPTID. NFP expression does not carry any prognostic significance.
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Mar 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.